SVF GP (Jersey) Ltd is 10% Owner at Arbutus Biopharma Corp (ABUS). They have made 2 open-market trades across 2 companies since 2017, most recently 2019-06-05.
CIK 0001716728
2 open-market purchases totalling $47.6M since 2017, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.